ES2049021T3 - Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion. - Google Patents

Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.

Info

Publication number
ES2049021T3
ES2049021T3 ES90902177T ES90902177T ES2049021T3 ES 2049021 T3 ES2049021 T3 ES 2049021T3 ES 90902177 T ES90902177 T ES 90902177T ES 90902177 T ES90902177 T ES 90902177T ES 2049021 T3 ES2049021 T3 ES 2049021T3
Authority
ES
Spain
Prior art keywords
solution
pct
recovering
epi protein
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902177T
Other languages
English (en)
Inventor
Ole Nordfang
Soren Carlsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2049021T3 publication Critical patent/ES2049021T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PROTEINA EPI ES AISLADA Y PURIFICADA DE UNA DISOLUCION DE FERMENTACION , UTILIZANDO UN METODO CROMATOGRAFICO, EN DONDE LA DISOLUCION QUE CONTIENE LA PROTEINA EPI ES APLICADA A UNA MATRIZ ACOPLADA CON HEGARINA, PREFERIBLEMENTE SELASOSA DE HEPARINA.
ES90902177T 1989-01-19 1990-01-18 Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion. Expired - Lifetime ES2049021T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK412389A DK412389D0 (da) 1989-01-19 1989-01-19 Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning

Publications (1)

Publication Number Publication Date
ES2049021T3 true ES2049021T3 (es) 1994-04-01

Family

ID=8130438

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902177T Expired - Lifetime ES2049021T3 (es) 1989-01-19 1990-01-18 Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.

Country Status (9)

Country Link
US (1) US5219993A (es)
EP (1) EP0454739B1 (es)
JP (1) JP2896605B2 (es)
AT (1) ATE99323T1 (es)
AU (1) AU5024490A (es)
DE (1) DE69005618T2 (es)
DK (2) DK412389D0 (es)
ES (1) ES2049021T3 (es)
WO (1) WO1990008158A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
PL374506A1 (en) 2001-10-15 2005-10-31 Chiron Corporation Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices

Also Published As

Publication number Publication date
DK412389D0 (da) 1989-01-19
DK0454739T3 (da) 1994-04-25
US5219993A (en) 1993-06-15
WO1990008158A1 (en) 1990-07-26
JPH05505385A (ja) 1993-08-12
EP0454739B1 (en) 1993-12-29
EP0454739A1 (en) 1991-11-06
JP2896605B2 (ja) 1999-05-31
ATE99323T1 (de) 1994-01-15
DE69005618D1 (de) 1994-02-10
DE69005618T2 (de) 1994-04-28
AU5024490A (en) 1990-08-13

Similar Documents

Publication Publication Date Title
DE69008423D1 (de) Dynamische Fixierung von Schweinsaortaklappen.
DK322188D0 (da) Fremgangsmaade til fremstilling af protein
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
ES2068404T3 (es) Un metodo para aislar el factor viii.
DE3477156D1 (en) Spectacle frame and parts thereof
DK0779896T3 (da) Ny fremgangsmåde til fremstilling af biologisk aktivt protein (TGF)
DE3784728T2 (de) Reinigung von rekombinantem interleukin-1.
NL960005I2 (nl) Optisch zuivere verbinding, en werkwijze voor de bereiding daarvan.
ES2049021T3 (es) Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.
PH31198A (en) Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
DE69403087D1 (de) Verfahren zur herstellung von 9-(2-hydroxy)-ethoxy-guanin
ES2054355T3 (es) Procedimiento de preparacion de la proteina c activada.
DE3565535D1 (en) Process for the preparation of optically active 1,4-dihydropyridines
ES2101694T3 (es) Expresion de edulcorantes proteinicos en levadura.
NO843750L (no) Immuninterferon og fremgangsmaate ved fremstilling derav
DE59611353D1 (de) Transketolase-verwandtes protein
IT1226147B (it) Processo per la preparazione di perfluoro (2 bromoetilviniletere).
DE59814423D1 (de) Verfahren zur herstellung von humaneigenblutzytokinen
IT8885571A0 (it) Procedimento per la decorazione di montature per occhiali e montatura decorata mediante il suddetto.
MX9700657A (es) Nuevo proceso para la produccion de proteina biologicamente activa.
IT1230746B (it) Processo per la preparazione del proteinato aspartilato.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 454739

Country of ref document: ES